Antimicrobial resistance (AMR) is one of the defining scientific, health, and economic challenges of our time. Today, AMR is responsible for 700,000 deaths worldwide, including more than 50,000 in the United States and Europe.
On the 26th of November, GHP, the Global Fund to fight AIDS, TB and Malaria (GAFTM) and KfW Development Bank were invited to discuss the challenges of antimicrobial resistance (AMR) and ways to address the issue. The confernce took place in Berlin and was carried out under the auspices of the Ministry for Economic Cooperation and Development (BMZ). Dr Maria Flachsbarth, Parliamentary State Secretary of the BMZ, as well as other specialists from various sectors, have emphasized the importance to combat AMR within the Global Health strategy. All relevant sectors (such as human medicine, veterinary medicine, agriculture) need to be considerd.
By 2050, the number of deaths worldwide could increase to 10 million globally – a much greater number of deaths than from cancer. Cumulatively, AMR could cost the global economy more than $100 trillion between 2014 and 2050. This makes AMR one of the most significant global health security issues that all countries have to face.